Rallis India Q1 profit jumps 31% on domestic formulation growth

The Soil & Plant Health segment grew 10% year-on-year, supported by portfolio management and pricing actions. Biostimulants and biofertilisers continued to contribute. The commercial launch of Aquafert for ginger and turmeric added to the segment's offerings.

The Seeds business reported revenue of ₹325 crore, up 6%. The company launched nine new products across cotton, paddy and millet, including two cotton hybrids for North India and a herbicide-tolerant direct-seed rice product under the Dhaanya brand.

Managing Director Gyanendra Shukla said the company strengthened its product portfolio through new introductions and improved profitability with pricing actions and cost optimisation. He said Rallis remains committed to delivering solutions for Indian agriculture through investments in innovation and customer-centricity.

The results come as the company faces a mixed demand environment. Domestic formulation demand supported growth, while the B2B export segment remained weak. The new product pipeline and field programmes are expected to sustain momentum in the coming quarters.